With increasing demands for advanced immunohistochemistry staining, a new system promises to deliver consistent, standardised results via a closed workflow which also places fewer demands on an already stretched laboratory workforce.
Advanced immunohistochemistry staining has become more and more complex over the last decades. The growing demand for more specific diagnosis and sub-diagnosis has increased the need for high quality staining. Recent years have also seen the number of patient cases rising along with increased regulation such as IVDR, all this against a backdrop of staff shortages in laboratories. Launched in 2022, the Tissue-Tek Genie from Sakura offers a completely new approach to staining quality and higher workloads.
It is not surprising that the workload of histopathology laboratories is increasing dramatically as the number of new cancer cases across Europe is estimated to grow by 22.5% over the next two decades, according to new estimates from the International Agency for Research on Cancer (IARC).1 In the UK this is being addressed by various initiatives such as the National Pathology Programme entitled Clinical Transformation Through Pathology Innovation.2 Today, healthcare providers already operate under high pressure as current systems are exposed to more than their full capacity. This presents significant challenges to laboratories
due to the nature of their work to manage complex tests, multiple workflows, and time-consuming sample preparation. In addition, errors arising from largely manual procedures cause extra work. For histopathology laboratories the implications of the growing burden of cancer are additional work pressures and need for new innovative solutions for automation and standardisation.
Quality and standardisation
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.